The Patent Finder
US

Corticosteroid Containing Orally Disintegrating Tablet Compositions for Eosinophilic Esophagitis

US 12,310,976 In force
OverviewFamilyAssignmentsSources & methods

Term ends Sep 5, 2034 · High confidence

Filed Dec 22, 2021 as application 17/559,068 · Granted May 27, 2025
Base term plus 48 days of patent term adjustment (USPTO delay) · capped by a resolved terminal disclaimer
Today
20 years from filing
2014 2034
Clock starts
Sep 5, 2014
Term ends
Sep 5, 2034
Granted
May 27, 2025
base term Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
48
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
Capped
Terminal disclaimer
Resolved from the filed document, referencing US 10,471,071, US 11,260,061.
0 of 2
Maintenance fees paid
Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.
12
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term runs 48 days past its 20-year base term on prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. 0 of 2 maintenance fees are paid so far. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Sep 5, 2014, when application PCT/US2014/054203, the earliest non-provisional in its chain, was filed (this one was filed Dec 22, 2021)Sep 5, 2034High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustment+48 days, USPTO patent term adjustment recordOct 23, 2034High confidence
Terminal disclaimer capDisclaimer resolved from the filed document (refs US 10,471,071, US 11,260,061)capped to Sep 5, 2034High confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events0 of 2 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderSep 5, 2034High confidence

This family

US 9,782,312In force
Sep 2034
Sep 2034
Application PCT/US2014/054023PCT application
no patent term
no patent term
US 10,471,071In force
Sep 2034
Sep 2034
Application 29/621,469Abandoned
not computed
not computed
US 11,166,961In force
Sep 2034
Sep 2034
US D904,073In force
Dec 2035
Dec 2035
US 11,260,061In force
Sep 2034
Sep 2034
US 12,310,976this patent
Sep 2034
Sep 2034
8 of 12 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Jan 19, 2022
Reel 58686, frame 568
Gosselin, Michael A.; Lai, Jin-wang; Venkatesh, Gopi M.Aptalis Pharmatech Inc.Assignment of Assignor's Interest
Jan 19, 2022
Reel 58686, frame 589
Adare Pharmaceuticals, Inc.Adare Development I, L.p.Change of Name
Jan 19, 2022
Reel 58767, frame 690
Aptalis Pharmatech, Inc.Adare Pharmaceuticals, Inc.Change of Name
Jan 19, 2022
Reel 58767, frame 693
Adare Development I, L.p.Adare Pharmaceuticals US, L.P.Change of Name
Jan 19, 2022
Reel 58767, frame 697
Adare Pharmaceuticals US, L.P.Ellodi Pharmaceuticals, L.p.Change of Name

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited